Advisors Asset Management, Inc. Moderna, Inc. Transaction History

Advisors Asset Management, Inc.

$5.28 Billion
Q3 2024

A detailed history of Advisors Asset Management, Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Advisors Asset Management, Inc. holds 4,740 shares of MRNA stock, worth $174,669. This represents 0.01% of its overall portfolio holdings.

Number of Shares

4,740

Previous 3,769 25.76%

Holding current value

$174,669

Previous $447,000 29.31%

% of portfolio

0.01%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$63.64 - $125.14 $61,794 - $121,510	971 Added 25.76%	4,740 $316,000
Q2 2024 Aug 14, 2024	BUY	$101.21 - $166.61 $215,982 - $355,545	2,134 Added 130.52%	3,769 $447,000
Q1 2024 May 14, 2024	SELL	$85.37 - $115.44 $8,110 - $10,966	-95 Reduced 5.49%	1,635 $174,000
Q4 2023 Feb 14, 2024	SELL	$69.51 - $104.43 $377,995 - $567,890	-5,438 Reduced 75.86%	1,730 $172,000
Q2 2023 Aug 14, 2023	SELL	$118.5 - $160.53 $242,925 - $329,086	-2,050 Reduced 22.24%	7,168 $870,000
Q1 2023 May 12, 2023	SELL	$135.66 - $197.02 $85,330 - $123,925	-629 Reduced 6.39%	9,218 $1.42 Million
Q4 2022 Feb 13, 2023	SELL	$118.38 - $210.04 $489,619 - $868,725	-4,136 Reduced 29.58%	9,847 $1.77 Million
Q3 2022 Nov 08, 2022	BUY	$118.07 - $194.18 $39,907 - $65,632	338 Added 2.48%	13,983 $1.65 Million
Q2 2022 Aug 08, 2022	BUY	$117.13 - $176.59 $328,315 - $494,981	2,803 Added 25.85%	13,645 $1.95 Million
Q1 2022 May 17, 2022	BUY	$126.46 - $235.05 $320,196 - $595,146	2,532 Added 30.47%	10,842 $1.87 Million
Q4 2021 Feb 15, 2022	BUY	$225.82 - $368.51 $429,735 - $701,274	1,903 Added 29.7%	8,310 $2.11 Million
Q3 2021 Nov 12, 2021	BUY	$221.9 - $484.47 $108,287 - $236,421	488 Added 8.24%	6,407 $2.47 Million
Q2 2021 Jul 30, 2021	BUY	$129.91 - $234.98 $133,937 - $242,264	1,031 Added 21.09%	5,919 $1.39 Million
Q1 2021 May 07, 2021	BUY	$109.18 - $185.98 $173,596 - $295,708	1,590 Added 48.21%	4,888 $640,000
Q4 2020 Feb 12, 2021	BUY	$65.74 - $169.86 $23,797 - $61,489	362 Added 12.33%	3,298 $345,000
Q3 2020 Nov 16, 2020	SELL	$54.34 - $94.85 $372,120 - $649,532	-6,848 Reduced 69.99%	2,936 $208,000
Q2 2020 Aug 12, 2020	BUY	$29.67 - $80.0 $190,985 - $514,960	6,437 Added 192.32%	9,784 $628,000
Q1 2020 May 15, 2020	SELL	$17.78 - $31.58 $1,120 - $1,989	-63 Reduced 1.85%	3,347 $100,000
Q4 2019 Feb 14, 2020	BUY	$13.93 - $21.28 $153 - $234	11 Added 0.32%	3,410 $67,000
Q3 2019 Nov 14, 2019	SELL	$12.26 - $18.07 $92,550 - $136,410	-7,549 Reduced 68.95%	3,399 $54,000
Q2 2019 Aug 14, 2019	BUY	$13.7 - $28.34 $149,987 - $310,266	10,948 New	10,948 $160,000

Others Institutions Holding MRNA

# of Institutions

954

Shares Held

241M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisors Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisors Asset Management, Inc. with notifications on news.

Account

Advisors Asset Management, Inc. Moderna, Inc. Transaction History